Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

pure nanodrug of 5, 10, 15, 20-tetra(4-pyridyl) porphyrin) and teniposide

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

5,10,15,20-tetrakis-(4-pyridyl)-21H,23H-porphine

5,10,15,20-tetra(4-pyridyl)-21H,23H-porphyrin 5,10,15,20-tetra-(4-pyridyl)-porphyrin 5,10,15,20-tetra(4-pyridyl)porphyrin meso-tetra(4-pyridyl)porphyrin meso-tetra-4-pyridyl-porphine tetrakis(4-pyridyl)porphyrin H2P(pPyr)4 H2TPyP TPyP MTP
Type Single Compound
Formula C40H26N8
Role raw materials
2

teniposide

VM-26
Type Single Compound
Formula C32H32O13S
Role raw materials

Properties

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 5,10,15,20-tetrakis-(4-pyridyl)-21H,23H-porphine
  • teniposide
  1. t9P1pyTjdlsORIX9k2qoM71aq5IbNKvuKnJ6hcgo42
Product

pure nanodrug of 5, 10, 15, 20-tetra(4-pyridyl) porphyrin) and teniposide

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial